Acute Effects of Modafinil on Brain Resting State Networks in Young Healthy Subjects

There is growing debate on the use of drugs that promote cognitive enhancement. Amphetamine-like drugs have been employed as cognitive enhancers, but they show important side effects and induce addiction. In this study, we investigated the use of modafinil which appears to have less side effects com...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 8; no. 7; p. e69224
Main Authors Esposito, Roberto, Cilli, Franco, Pieramico, Valentina, Ferretti, Antonio, Macchia, Antonella, Tommasi, Marco, Saggino, Aristide, Ciavardelli, Domenico, Manna, Antonietta, Navarra, Riccardo, Cieri, Filippo, Stuppia, Liborio, Tartaro, Armando, Sensi, Stefano L.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 25.07.2013
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:There is growing debate on the use of drugs that promote cognitive enhancement. Amphetamine-like drugs have been employed as cognitive enhancers, but they show important side effects and induce addiction. In this study, we investigated the use of modafinil which appears to have less side effects compared to other amphetamine-like drugs. We analyzed effects on cognitive performances and brain resting state network activity of 26 healthy young subjects. A single dose (100 mg) of modafinil was administered in a double-blind and placebo-controlled study. Both groups were tested for neuropsychological performances with the Raven's Advanced Progressive Matrices II set (APM) before and three hours after administration of drug or placebo. Resting state functional magnetic resonance (rs-FMRI) was also used, before and after three hours, to investigate changes in the activity of resting state brain networks. Diffusion Tensor Imaging (DTI) was employed to evaluate differences in structural connectivity between the two groups. Protocol ID: Modrest_2011; NCT01684306; http://clinicaltrials.gov/ct2/show/NCT01684306. Results indicate that a single dose of modafinil improves cognitive performance as assessed by APM. Rs-fMRI showed that the drug produces a statistically significant increased activation of Frontal Parietal Control (FPC; p<0.04) and Dorsal Attention (DAN; p<0.04) networks. No modifications in structural connectivity were observed. Overall, our findings support the notion that modafinil has cognitive enhancing properties and provide functional connectivity data to support these effects. ClinicalTrials.gov NCT01684306 http://clinicaltrials.gov/ct2/show/NCT01684306.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
Conceived and designed the experiments: RE F. Cilli VP SLS. Performed the experiments: RE F. Cilli VP SLS AF A. Macchia MT AS. Analyzed the data: RE F. Cieri VP DC SLS AF A. Macchia MT AS A. Manna RN. Wrote the paper: RE F. Cilli VP SLS F. Cieri. Critical revision: AT LS.
Competing Interests: SLS is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0069224